CytoRecovery
Blacksburg, US · Founded 2017 · Delaware corporation · 1 known investors
Cyto Recovery develops technology for label-free cell sorting and gentle sample cleanup for cell populations, aimed at life-science and research users. Its products are positioned as tools for separating and purifying cells without labeling.
BiotechDeep TechHardware
Founders & leadership
SC
Stephen C. TurnerCEO, President, Secretary
JR
James RameyDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$2.1MraisedJul 2022 · 24 investors · BiotechnologyRule 506(b)
▶$2.1MraisedJul 2022 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Vinod ChachraDirector
- James RameyDirector
- Stephen C. TurnerExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $2.1M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1.3MraisedApr 2021 · 29 investors · BiotechnologyRule 506(b)
▶$1.3MraisedApr 2021 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen C. TurnerExecutive Officer, Director
- James RameyDirector
- Offering amount
- $1.8M
- Amount sold
- $1.3M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$500KraisedApr 2019 · 13 investors · Other TechnologyRule 506(b)
▶$500KraisedApr 2019 · 13 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Leonard P. HarrisDirector
- Stephen C. TurnerExecutive Officer, Director
- James RameyDirector
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.